BioMed Laboratory
 School of Life Sciences
 Nanjing University

Lab-Intro > Publications
  •   Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma. Zhou G., M. Lu, J. Chen, C. Li, J. Zhang, J. Chen, X. Shi and S. Wu. Tumour Biol. 2015; 36 (11): 8845-52.
  •   Honeysuckle-encoded atypical microRNA2911 directly targets influenza A viruses. Zhou Z., X. Li, J. Liu, L. Dong, Q. Chen, J. Liu, H. Kong, Q. Zhang, X. Qi, D. Hou, L. Zhang, G. Zhang, Y. Liu, Y. Zhang, J. Li, J. Wang, X. Chen, H. Wang, J. Zhang, H. Chen, K. Zen and C. Y. Zhang. Cell Res. 2015; 25 (1
  •   Linear polyethylenimine-plasmid DNA nanoparticles are ototoxic to the cultured sensory epithelium of neonatal mice. Zhou H., X. Ma, Y. Liu, L. Dong, Y. Luo, G. Zhu, X. Qian, J. Chen, L. Lu, J. Wang and X. Gao. Mol Med Rep. 2015; 11 (6): 4381-8.
  •   C/EBP-beta-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer. Sun D., C. Wang, S. Long, Y. Ma, Y. Guo, Z. Huang, X. Chen, C. Zhang, J. Chen and J. Zhang. Br J Cancer. 2015; 112 (9): 1491-500.
  •   Autophagy mediated CoCrMo particle-induced peri-implant osteolysis by promoting osteoblast apoptosis. Wang, Z., N. Liu, K. Liu, G. Zhou, J. Gan, Z. Wang, T. Shi, W. He, L. Wang, T. Guo, N. Bao, R. Wang, Z. Huang, J. Chen, L. Dong, J. Zhao and J. Zhang. Autophagy. 2015:0.
  •   Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes. Zhao, S., Y. Zhang, X. Zheng, X. Tu, H. Li, J. Chen, Y. Zang and J. Zhang. J Cell Physiol. 2015;230(11):2706-2717.
  •   Association between the expression of T-cadherin and vascular endothelial growth factor and the prognosis of patients with gastric cancer. Wei, B., H. Shi, X. Lu, A. Shi, Y. Cheng and L. Dong. Mol Med Rep. 2015;12(2):2075-2081.
  •   The fibroblast expression of RANKL in CoCrMo-particle-induced osteolysis is mediated by ER stress and XBP1s. Wang, Z., Z. Huang, J. Gan, N. Liu, G. Zhou, T. Shi, Z. Wang, R. Wang, N. Bao, T. Guo, J. Chen, J. Zhang, L. Dong and J. Zhao. Acta Biomater. 2015;24:352-360.
  •   MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells. Tu, X., X. Zheng, H. Li, Z. Cao, H. Chang, S. Luan, J. Zhu, J. Chen, Y. Zang and J. Zhang. Toxicol Sci. 2015;146(1):157-169.
  •   Dual TNF-alpha/IL-12p40 Interference as a Strategy to Protect Against Colitis Based on miR-16 Precursors With Macrophage Targeting Vectors. Huang, Z., J. Ma, M. Chen, H. Jiang, Y. Fu, J. Gan, L. Dong, J. Zhang and J. Chen. Mol Ther. 2015;23(10):1611-1621.
  •   An orally administrated nucleotide-delivery vehicle targeting colonic macrophages for the treatment of inflammatory bowel disease. Huang, Z., J. Gan, L. Jia, G. Guo, C. Wang, Y. Zang, Z. Ding, J. Chen, J. Zhang and L. Dong. Biomaterials. 2015;48:26-36.
  •   Corona-directed nucleic Acid delivery into hepatic stellate cells for liver fibrosis therapy. Zhang, Z., C. Wang, Y. Zha, W. Hu, Z. Gao, Y. Zang, J. Chen, J. Zhang and L. Dong. ACS Nano. 2015;9(3):2405-2419.
  •   CD226 rs727088A>G polymorphism increases the susceptibility to gastric cancer in Chinese populations. Zhang, C., Z. Ding, G. Lv, J. Li, J. F. Zhang and P. Zhou. Gene. 2015;557(1):92-97.
  •   Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy. Zhan, X., L. Jia, Y. Niu, H. Qi, X. Chen, Q. Zhang, J. Zhang, Y. Wang, L. Dong and C. Wang. Biomaterials. 2014;35(38):10046-10057.
  •   Lower Irisin Level in Patients with Type 2 Diabetes Mellitus: a Case-control Study and Meta-analysis. Zhang, C., Z. Ding, G. Lv, J. Li, P. Zhou and J. Zhang. J Diabetes. 2014.
  •   Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth. Yin, Y., X. Cai, X. Chen, H. Liang, Y. Zhang, J. Li, Z. Wang, X. Chen, W. Zhang, S. Yokoyama, C. Wang, L. Li, L. Li, D. Hou, L. Dong, T. Xu, T. Hiroi, F. Yang, H. Ji, J. Zhang, K. Zen and C. Y. Z
  •   miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC. Wang, N., H. Liang, Y. Zhou, C. Wang, S. Zhang, Y. Pan, Y. Wang, X. Yan, J. Zhang, C. Y. Zhang, K. Zen, D. Li and X. Chen. PLoS One. 2014;9(8):e105570.
  •   A tumor environment responsive doxorubicin-loaded nanoparticle for targeted cancer therapy. Zhu, Q., L. Jia, Z. Gao, C. Wang, H. Jiang, J. Zhang and L. Dong. Mol Pharm. 2014;11(10):3269-3278.
  •   MicroRNA-101 suppresses liver fibrosis by targeting the TGFbeta signalling pathway. Tu, X., H. Zhang, J. Zhang, S. Zhao, X. Zheng, Z. Zhang, J. Zhu, J. Chen, L. Dong, Y. Zang and J. Zhang. J Pathol. 2014;234(1):46-59.
  •   A 3-D artificial colon tissue mimic for the evaluation of nanoparticle-based drug delivery system. Huang, Z., Z. Wang, S. Long, H. Jiang, J. Chen, J. Zhang and L. Dong. Mol Pharm. 2014;11(7):2051-2061.